**Core Concept**
Down syndrome, also known as Trisomy 21, is a genetic disorder caused by an extra copy of chromosome 21. During the first trimester, ultrasound (USG) findings can be crucial in identifying potential cases. One of the earliest detectable markers is the nuchal translucency (NT), which refers to the thickness of the fluid-filled space at the back of the fetal neck.

**Why the Correct Answer is Right**
The correct answer is related to the nuchal translucency (NT) measurement. An NT of 3.5 mm or more is considered abnormal and increases the risk of Down syndrome. This is because the excess fluid in the nuchal area can indicate an increased risk of aneuploidy, including Trisomy 21. The NT measurement is typically performed between 11 and 14 weeks of gestation, and a high NT is often used in conjunction with other markers, such as maternal age and fetal markers, to assess the risk of Down syndrome.

**Why Each Wrong Option is Incorrect**
* **Option A:** **Nuchal edema** is not a specific marker for Down syndrome during the first trimester. While it can be associated with various fetal anomalies, it is not a reliable indicator of Trisomy 21.
* **Option B:** **Shortened long bone** is more commonly associated with skeletal dysplasias, such as achondroplasia, rather than Down syndrome. In Down syndrome, the long bones are typically normal in length.
* **Option C:** **Increased fetal heart rate** is not a specific marker for Down syndrome during the first trimester. While fetal heart rate abnormalities can be associated with various fetal anomalies, they are not a reliable indicator of Trisomy 21.
* **Option D:** **Polyhydramnios** is not typically associated with Down syndrome during the first trimester. Polyhydramnios is more commonly associated with fetal anomalies that affect the fetal gastrointestinal tract, such as esophageal atresia.

**Clinical Pearl / High-Yield Fact**
The nuchal translucency (NT) measurement is a key component of the first-trimester screening for Down syndrome. A high NT is associated with an increased risk of aneuploidy, including Trisomy 21. This marker is often used in conjunction with other markers, such as maternal age and fetal markers, to assess the risk of Down syndrome.

**Correct Answer:** C.